100 related articles for article (PubMed ID: 28106922)
21. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
[TBL] [Abstract][Full Text] [Related]
22. Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study.
Huang W; Goldberg RJ; Anderson FA; Cohen AT; Spencer FA
J Thromb Thrombolysis; 2016 Apr; 41(3):525-38. PubMed ID: 26847621
[TBL] [Abstract][Full Text] [Related]
23. Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study.
van Schouwenburg IM; Mahmoodi BK; Veeger NJ; Kluin-Nelemans HC; Gansevoort RT; Meijer K
Br J Haematol; 2012 Mar; 156(5):667-71. PubMed ID: 22233096
[TBL] [Abstract][Full Text] [Related]
24. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B
Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364
[TBL] [Abstract][Full Text] [Related]
25. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study.
Gándara E; Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; Le Gal G; Solymoss S; Crowther M; Carrier M; Langlois N; Kovacs J; Little Ma J; Carson N; Ramsay T; Rodger MA
Thromb Haemost; 2013 Dec; 110(6):1172-9. PubMed ID: 24067945
[TBL] [Abstract][Full Text] [Related]
26. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study.
Di Minno MN; Dentali F; Lupoli R; Ageno W
Circulation; 2014 Jan; 129(4):497-503. PubMed ID: 24146249
[TBL] [Abstract][Full Text] [Related]
27. Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.
Walker AJ; Baldwin DR; Card TR; Powell HA; Hubbard RB; Grainge MJ
Br J Cancer; 2016 Jun; 115(1):115-21. PubMed ID: 27253177
[TBL] [Abstract][Full Text] [Related]
28. F11 is associated with recurrent VTE in women. A prospective cohort study.
Bruzelius M; Ljungqvist M; Bottai M; Bergendal A; Strawbridge RJ; Holmström M; Silveira A; Kieler H; Hamsten A; Lärfars G; Odeberg J
Thromb Haemost; 2016 Jan; 115(2):406-14. PubMed ID: 26423325
[TBL] [Abstract][Full Text] [Related]
29. Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women.
Everett BM; Glynn RJ; Buring JE; Ridker PM
J Thromb Haemost; 2009 Apr; 7(4):588-96. PubMed ID: 19187075
[TBL] [Abstract][Full Text] [Related]
30. Retrospective evaluation of venous thromboembolism: Are all transient provoking events the same?
Chua CC; Lim HY; Tacey M; Nandurkar H; Ho P
Eur J Haematol; 2017 Jul; 99(1):18-26. PubMed ID: 28321922
[TBL] [Abstract][Full Text] [Related]
31. The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study.
Adiamah A; Ban L; West J; Humes DJ
Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31617892
[TBL] [Abstract][Full Text] [Related]
32. Risk of Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study.
Albertsen IE; Nielsen PB; Søgaard M; Goldhaber SZ; Overvad TF; Rasmussen LH; Larsen TB
Am J Med; 2018 Sep; 131(9):1067-1074.e4. PubMed ID: 30266273
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
34. Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study.
Fournier JP; Duijnhoven RG; Renoux C; Dell'Aniello S; Klungel OH; Suissa S
Menopause; 2014 Sep; 21(9):1023-6. PubMed ID: 24937027
[TBL] [Abstract][Full Text] [Related]
35. How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
Lekovic D; Miljic P; Dmitrovic A; Thachil J
Blood Rev; 2017 May; 31(3):151-157. PubMed ID: 27998619
[TBL] [Abstract][Full Text] [Related]
36. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease and mortality after a first episode of venous thromboembolism in young and middle-aged women.
Ljungqvist M; Holmström M; Kieler H; Odeberg J; Lärfars G
Thromb Res; 2016 Feb; 138():80-85. PubMed ID: 26826509
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
[TBL] [Abstract][Full Text] [Related]
39. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for venous thromboembolism during pregnancy.
Jensen TB; Gerds TA; Grøn R; Bretler DM; Schmiegelow MD; Andersson C; Azimi A; Gislason G; Torp-Pedersen C; Olesen JB
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1283-91. PubMed ID: 24130063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
